Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Hospitalizations for IBD Among Medicare Beneficiaries

researchsnappy by researchsnappy
December 30, 2019
in Healthcare Research
0
Hospitalizations for IBD Among Medicare Beneficiaries
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

Table.  Hospitalizations for inflammatory bowel disease (IBD)* as the principal diagnosis among Medicare fee-for-service beneficiaries,
† by age, sex, race/ethnicity, and urban-rural status of residence — United States, 2017
Characteristic No. of hospitalizations Hospitalization rate,§ (95% CI) Surgery rate,¶,**,†† (95% CI) 30-Day readmission rate,¶,§§ (95% CI) 30-Day mortality rate,¶,¶¶ (95% CI) Length of stay (days)** geometric mean,*** (95% CI)
Crohn’s disease†††
Total 4,782 15.5 (15.0–15.9) 17.4 (16.3–18.4) 15.8 (14.5–17.1) 2.7 (2.2–3.1) 3.9 (3.8–4.0)
Age group (yrs)
65–74 2,912 17.1 (16.5–17.7) 19.3 (17.8–20.7) 15.4 (13.7–17.0) 1.7 (1.2–2.1) 3.8 (3.7–3.9)
≥75 1,870 13.7 (13.1–14.4) 14.4 (12.8–16.0) 16.5 (14.3–18.7) 4.2 (3.3–5.1) 4.1 (3.9–4.2)
Sex
Men 2,001 14.1 (13.5–14.8) 19.0 (17.3–20.8) 17.6 (15.5–19.7) 3.0 (2.3–3.8) 3.8 (3.6–3.9)
Women 2,781 16.7 (16.1–17.3) 16.1 (14.8–17.5) 14.5 (12.7–16.1) 2.4 (1.8–3.0) 4.0 (3.9–4.1)
Race/Ethnicity
White, non-Hispanic 4,227 16.9 (16.4–17.5) 17.5 (16.4–18.7) 16.1 (14.6–17.5) 2.6 (2.1–3.0) 4.0 (3.9–4.0)
Black, non-Hispanic 250 10.3 (9.0–11.5) 10.8 (7.0–14.6) 14.7 (9.1–20.2) —§§§ 4.2 (4.0–4.5)
Other or unknown¶¶¶ 305 8.8 (7.8–9.8) 20.3 (15.8–24.8) 13.1 (8.3–17.7) —§§§ 4.1 (3.8–4.3)
Beneficiary residence****
Urban 3,938 16.0 (15.5–16.5) 17.0 (15.8–18.2) 16.1 (14.6–17.5) 2.6 (2.1–3.1) 3.9 (3.8–4.0)
Rural 844 13.4 (12.5–14.3) 19.0 (16.3–21.6) 14.5 (11.3–17.7) 3.1 (1.9–4.3) 3.8 (3.7–4.0)
Ulcerative colitis†††
Total 4,932 16.2 (15.8–16.7) 11.2 (10.3–12.1) 16.0 (14.6–17.3) 3.8 (3.3–4.4) 4.1 (4.0–4.2)
Age group (yrs)
65–74 2,395 14.1 (13.5–14.6) 15.6 (14.1–17.0) 14.5 (12.7–16.3) 2.1 (1.5–2.7) 4.1 (4.0–4.3)
≥75 2,537 18.6 (17.9–19.4) 7.0 (6.0–8.0) 17.4 (15.5–19.3) 5.5 (4.6–6.4) 4.0 (3.9–4.2)
Sex
Men 1,872 13.5 (12.9–14.2) 16.9 (15.2–18.6) 17.6 (15.3–19.8) 4.0 (3.1–4.9) 4.2 (4.1–4.4)
Women 3,060 18.4 (17.7–19.0) 7.6 (6.7–8.6) 15.0 (13.4–16.6) 3.7 (3.1–4.4) 4.0 (3.9–4.1)
Race/Ethnicity
White, non-Hispanic 4,205 17.0 (16.5–17.5) 11.5 (10.6–12.5) 16.0 (14.6–17.4) 4.0 (3.4–4.6) 4.0 (3.9–4.0)
Black, non-Hispanic 325 14.0 (12.4–15.5) 7.1 (4.3–9.9) 18.9 (13.5–24.1) —§§§ 4.2 (4.0–4.5)
Other or unknown¶¶¶ 402 12.0 (10.8–13.3) 10.7 (7.7–13.7) 13.2 (8.9–17.4) —§§§ 4.1 (3.8–4.3)
Beneficiary residence****
Urban 4,110 17.0 (16.5–17.6) 10.8 (9.9–11.8) 16.2 (14.7–17.6) 3.9 (3.3–4.5) 4.1 (4.0–4.2)
Rural 819 13.2 (12.2–14.1) 12.9 (10.6–15.2) 14.9 (11.5–18.1) 3.4 (2.2–4.7) 4.0 (3.8–4.2)

Abbreviation: CI = confidence interval.
*IBD encompasses Crohn’s disease and ulcerative colitis.
†The number of eligible Medicare beneficiaries aged ≥65 years in 2017 in the United States was approximately 30,658,000.
§Hospitalizations per 100,000 Medicare enrollees, age-adjusted to the 2000 U.S. Standard Population aged ≥65 years based on two age groups (65–74 years and ≥75 years), except for age-specific analysis. https://www.cdc.gov/nchs/data/statnt/statnt20.pdf.
¶Per 100 hospital stays.
**The denominator is number of hospital admissions. To calculate surgery rate and geometric mean of length of stay, n = 4,782 for Crohn’s disease and n = 4,932 for ulcerative colitis.
†† International Classification of Diseases, Tenth Edition, Procedure Coding System procedure codes involving small and large intestine include partial resection (0DB80ZZ, 0DB90ZZ, 0DBA0ZZ, 0DBB0ZZ, 0DBC0ZZ, 0DBE0ZZ, 0DBF0ZZ, 0DBG0ZZ, 0DBH0ZZ, 0DBK0ZZ, 0DBL0ZZ, 0DBM0ZZ, 0DBN0ZZ, 0DBP0ZZ, 0DB83ZZ, 0DB93ZZ, 0DBA3ZZ, 0DBB3ZZ, 0DBC3ZZ, 0DBE3ZZ, 0DBF3ZZ, 0DBG3ZZ, 0DBH3ZZ, 0DBK3ZZ, 0DBL3ZZ, 0DBM3ZZ, 0DBN3ZZ, 0DBP3ZZ, 0DB84ZZ, 0DB94ZZ, 0DBA4ZZ, 0DBB4ZZ, 0DBC4ZZ, 0DBE4ZZ, 0DBF4ZZ, 0DBG4ZZ, 0DBH4ZZ, 0DBK4ZZ, 0DBL4ZZ, 0DBM4ZZ, 0DBN4ZZ, 0DBP4ZZ, 0DB87ZZ, 0DB97ZZ, 0DBA7ZZ, 0DBB7ZZ, 0DBC7ZZ, 0DBE7ZZ, 0DBF7ZZ, 0DBG7ZZ, 0DBH7ZZ, 0DBK7ZZ, 0DBL7ZZ, 0DBM7ZZ, 0DBN7ZZ, 0DBP7ZZ, 0DB88ZZ, 0DB98ZZ, 0DBA8ZZ, 0DBB8ZZ, 0DBC8ZZ, 0DBE8ZZ, 0DBF8ZZ, 0DBG8ZZ, 0DBH8ZZ, 0DBK8ZZ, 0DBL8ZZ, 0DBM8ZZ, 0DBN8ZZ, 0DBP8ZZ) and total resection (0DT80ZZ, 0DT90ZZ, 0DTA0ZZ, 0DTB0ZZ, 0DTC0ZZ, 0DTE0ZZ, 0DTF0ZZ, 0DTG0ZZ, 0DTH0ZZ, 0DTK0ZZ, 0DTL0ZZ, 0DTM0ZZ, 0DTN0ZZ, 0DTP0ZZ, 0DT84ZZ, 0DT94ZZ, 0DTA4ZZ, 0DTB4ZZ, 0DTC4ZZ, 0DTE4ZZ, 0DTF4ZZ, 0DTG4ZZ, 0DTH4ZZ, 0DTK4ZZ, 0DTL4ZZ, 0DTM4ZZ, 0DTN4ZZ, 0DTP4ZZ, 0DT87ZZ, 0DT97ZZ, 0DTA7ZZ, 0DTB7ZZ, 0DTC7ZZ, 0DTE7ZZ, 0DTF7ZZ, 0DTG7ZZ, 0DTH7ZZ, 0DTK7ZZ, 0DTL7ZZ, 0DTM7ZZ, 0DTN7ZZ, 0DTP7ZZ, 0DT88ZZ, 0DT98ZZ, 0DTA8ZZ, 0DTB8ZZ, 0DTC8ZZ, 0DTE8ZZ, 0DTF8ZZ, 0DTG8ZZ, 0DTH8ZZ, 0DTK8ZZ, 0DTL8ZZ, 0DTM8ZZ, 0DTN8ZZ, 0DTP8ZZ).§§30-day readmission rate was calculated as the number of all-cause readmissions to acute care, nonfederal hospitals within 30 days from the discharge date associated with an index admission per 100 stays. Index admissions were nonfederal acute-care hospital admissions with Crohn’s disease or ulcerative colitis as the principal diagnosis, had a live discharge, and had a routine discharge to home or skilled nursing facility. To ensure the calculation of the complete 30-day readmission, index admissions with discharge date in December 2017 were excluded. Readmissions were defined as all-cause acute admissions whose discharge destinations were not against medical advice or expired. Multiple readmissions within the 30-day time frame from one index admission were counted as one readmission. A readmission from a previous index admission could be also counted as a new index admission if it met the selection criteria for an index admission (https://www.medicare.gov/hospitalcompare/data/30-day-measures.html). To calculate 30-day all-cause readmission rate, n = 3,022 for Crohn’s disease; n = 3,060 for ulcerative colitis.
¶¶30-day mortality rate was defined as number of all-cause deaths occurred within 30 days from IBD-related admissions per 100 hospital stays. Hospitalizations were excluded if patients were discharged against medical advice. More information is available at https://www.medicare.gov/hospitalcompare/data/30-day-measures.html. To calculate 30-day all-cause readmission rate, n = 4,781 for Crohn’s disease; n = 4,932 for ulcerative colitis.
***Geometric mean is the xth root of the product of the length of stay (days) from x patients (x indicates the number of patients), which, because it is not influenced by outliers, is used here rather than arithmetic mean.
††† International Classification of Diseases, Tenth Edition, Clinical Modification diagnosis codes K50 (Crohn’s disease) and K51 (ulcerative colitis).
§§§Data were suppressed according to the cell size suppression (https://www.resdac.org/articles/cms-cell-size-suppression-policy) or if the relative standard error was >0.3.
¶¶¶Other includes Hispanic, Asian, Native American, and all others.
****Urban areas include large metro, large fringe metro, medium metro, or small metro. Rural areas include micropolitan and noncore. The definition is based on 2013 National Center for Health Statistics Urban-Rural Classification Scheme for Counties (https://www.cdc.gov/nchs/data/series/sr_02/sr02_166.pdf).

Previous Post

20 stocks to buy in 2020 including Apple, Amazon and Microsoft

Next Post

Management Consulting Market to Reach $295 Billion by 2020, Says Beroe Inc

Next Post
Global Sea Food Market Currently Estimated at $147.04 Billion, Says Beroe Inc

Management Consulting Market to Reach $295 Billion by 2020, Says Beroe Inc

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News

3 Best Market Research Certifications in High Demand

PRC needs full funding to do its job | My View

Plant-based Chicken Market 2021 by Global Key Players, Types, Applications, Countries, Industry Size and Forecast to 2030 – Energy Siren

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2023 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2023 researchsnappy.com